For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.
Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines suitable for use in commercial chickens.
Scope of the Report:
This report focuses on the Newcastle Disease Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The classification of Newcastle Disease Vaccine includes Live Vaccines and Killed Vaccines. The proportion of Killed Vaccines in 2016 is about 77.1%, These vaccines are made with virus that is alive and able to infect cells. Strains of virus of low or moderate virulence are used. They mimic natural infection and induce all three immune responses. And the proportion of Live Vaccines in 2016 is about 22.9%.
Newcastle Disease Vaccine is application in Chicken, Duck & Goose and others. The most of Newcastle Disease Vaccine is used in Chicken, and the market share in 2016 is about 87.5%.
Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans. Newcastle disease can causes devastating losses in both commercial and village chickens. So Newcastle Disease Vaccine is necessary for farms with Chicken, Duck & Goose, etc.
Market competition is intense. Merial, CEVA, QYH Biotech, Ringpu Biology, etc. are the leader of this industry. With the development of society and the changing of consumer demand, the Newcastle Disease Vaccine industry will be more and more popular in the future.
The worldwide market for Newcastle Disease Vaccine is expected to grow at a CAGR of roughly 3.6% over the next five years, will reach 340 million US$ in 2023, from 280 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- QYH Biotech
- Ringpu Biology
- Harbin Veterinary Research Institute
- Merck Animal Health
- ChengDu Tecbond
- Elanco (Lohmann)
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Live Vaccines
- Killed Vaccines
Market Segment by Applications, can be divided into
- Duck & Goose
There are 15 Chapters to deeply display the global Newcastle Disease Vaccine market.
Chapter 1, to describe Newcastle Disease Vaccine Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Newcastle Disease Vaccine, with sales, revenue, and price of Newcastle Disease Vaccine, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Newcastle Disease Vaccine, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Newcastle Disease Vaccine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Newcastle Disease Vaccine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source